Susquehanna Portfolio Strategies »

Ultragenyx Pharmaceutical shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2024-06-30 $294k 7.1k 41.10
2024-03-31 $1.1M 24k 46.69

More positions owned by Susquehanna Portfolio Strategies

Thermo Fisher Scientific (TMO)
Stryker Corporation (SYK)
Visa Com Cl A (V)
Truist Financial Corp equities (TFC)
Merck & Co (MRK)
Hartford Financial Services (HIG)
Public Storage (PSA)
ResMed (RMD)
Morgan Stanley Com New (MS)
Block Cl A (SQ)
Coca-Cola Company (KO)
Chipotle Mexican Grill (CMG)
Travelers Companies (TRV)
Southern Company (SO)
Huntington Bancshares Incorporated (HBAN)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
Sands Capital Management
State Street Corporation
T. Rowe Price Associates
Wellington Management Company
ClearBridge Advisors
Federated Investors
Rtw Investments
Rock Springs Capital Management
Invesco
Deutsche Bank Aktiengesellschaft
Alkeon Capital Management
Alliancebernstein
Baker Bros. Advisors

View all funds holding Ultragenyx Pharmaceutical